OKYO Pharma Ltd
NASDAQ:OKYO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OKYO Pharma Ltd
NASDAQ:OKYO
|
UK |
|
Nitiraj Engineers Ltd
NSE:NITIRAJ
|
IN |
|
N
|
Northern Region Cement Company SJSC
SAU:3004
|
SA |
|
I
|
International Flavors & Fragrances Inc
SWB:IFF
|
US |
|
I
|
Idomoo Ltd
TASE:IDMO
|
IL |
|
D
|
Deutsche Telekom AG
OTC:DTEGY
|
DE |
|
S
|
Shake Shack Inc
SWB:9SH
|
US |
|
V
|
Vibe Growth Corp
CNSX:VIBE
|
CA |
|
E
|
Exxaro Resources Ltd
JSE:EXX
|
ZA |
|
Italgas SpA
MIL:IG
|
IT |
|
Rolls-Royce Holdings PLC
OTC:RYCEF
|
UK |
|
Codan Ltd
ASX:CDA
|
AU |
|
E
|
Evoke PLC
SWB:C8V
|
GI |
|
S
|
SoftBank Group Corp
F:SFT
|
JP |
|
U
|
Unity Software Inc
DUS:US3
|
US |
|
A
|
Agritek Holdings Inc
OTC:AGTK
|
US |
|
Equinor ASA
OSE:EQNR
|
NO |
Bankruptcy Probability
OKYO Pharma Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OKYO Pharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
OKYO Pharma Ltd
NASDAQ:OKYO
|
70.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OKYO Pharma Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OKYO Pharma Ltd has no debt.
You can find a full breakdown on its Balance Sheet.